Kiniksa Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Kiniksa Pharmaceuticals | 8-K: Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution
Kiniksa Pharmaceuticals | 8-K: Current report
Kiniksa Pharmaceuticals | 8-K: Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio Execution
Kiniksa Pharmaceuticals | 8-K: Kiniksa Pharmaceuticals Reports Second Quarter 2023 Financial Results and Recent Portfolio Execution
Kiniksa Pharmaceuticals | 8-K: Current report
Kiniksa Pharmaceuticals | 8-K: Kiniksa Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent Portfolio Execution
Kiniksa Pharmaceuticals | DEF 14A: Definitive proxy statements
Kiniksa Pharmaceuticals | 8-K: Current report
Kiniksa Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Kiniksa Pharmaceuticals | 8-K: Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Portfolio Execution
Kiniksa Pharmaceuticals | 8-K: Current report
Kiniksa Pharmaceuticals | 8-K: Kiniksa Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Kiniksa Pharmaceuticals | 8-K: Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Kiniksa Pharmaceuticals | 8-K: Current report
Kiniksa Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
Kiniksa Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
Kiniksa Pharmaceuticals | 8-K: Kiniksa Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
Kiniksa Pharmaceuticals | DEFA14A: Others
Kiniksa Pharmaceuticals | DEF 14A: Definitive proxy statements
No Data